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Abstract
Background—Cesarean delivery in the second stage of labor is common, whereas the frequency 
of operative vaginal delivery has been declining. However, data comparing outcomes for attempted 
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operative vaginal delivery in the second stage versus cesarean in the second stage are scant. 
Previous studies that examine operative vaginal delivery have compared it to a baseline risk of 
complications from a spontaneous vaginal delivery and cesarean delivery. However, when a 
woman has a need for intervention in the second stage, spontaneous vaginal delivery is not an 
option she or the provider can choose. Thus, the appropriate clinical comparison is cesarean versus 
operative vaginal delivery.
Objective—Our objective was to compare outcomes by the first attempted operative delivery 
(vacuum, forceps versus cesarean delivery) in patients needing second stage assistance at a fetal 
station of +2 or below.
Study Design—Secondary analysis of an observational obstetric cohort in 25 academically-
affiliated U.S. hospitals over a three-year period. A subset of ≥37 weeks, non-anomalous, vertex, 
singletons, with no prior vaginal delivery who reached a station of +2 or below and underwent an 
attempt at an operative delivery were included. Indications included for operative delivery were: 
failure to descend, non-reassuring fetal status, labor dystocia or maternal exhaustion. The primary 
outcomes included a composite neonatal outcome (death, fracture, length of stay ≥3 days beyond 
mother’s, low Apgar, subgaleal hemorrhage, ventilator support, hypoxic encephalopathy, brachial 
plexus injury, facial nerve palsy) and individual maternal outcomes (postpartum hemorrhage, third 
and fourth degree tears [severe lacerations], and postpartum infection). Outcomes were examined 
by the three attempted modes of delivery. Odds ratios were calculated for primary outcomes 
adjusting for confounders. Final mode of delivery was quantified.
Results—2531 women met inclusion criteria. Vacuum attempt was associated with the lowest 
frequency of the neonatal composite (4.2% vs. 6.1% vaginal forceps vs. 6.9% cesarean) and 
maternal complications (Postpartum infection 0.2% vs. 0.9% forceps vs. 5.3% cesarean, 
Postpartum hemmorhage 1.4% vs. 2.8% forceps vs. 3.8% cesarean), except for severe lacerations 
(19.1% vs. 33.8% forceps vs. 0% cesarean). When confounders were taken into account, both 
forceps (odds ratio 0.16, 95%CI 0.05-0.49) and vacuum (odds ratio 0.04, 95%CI 0.01-0.17) were 
associated with a significantly lower odds of Post partuminfection. The neonatal composite and 
Postpartum hemmorhage were not significantly different between modes of attempted delivery. 
Cesarean occurred in 6.4% and 4.4% of attempted vacuum and forceps groups (P=.04).
Conclusion—In patients needing second stage delivery assistance with a station of +2 or below, 
attempted operative vaginal delivery was associated with a lower frequency of Postpartum 
infection, but higher frequency of severe lacerations.
Keywords
Forceps; Vacuum; second stage of labor; operative vaginal delivery
Introduction
Cesarean delivery in the second stage of labor is common in the United Staters and 
represents 23% of primary cesarean deliveries. 1The high frequency of cesarean deliveries 
could potentially be offset by first attempting an operative vaginal delivery. However in 
recent years, the frequency of operative vaginal delivery has been declining. Operative 
vaginal deliveries dropped from 9.01% in 1990 to 3.30% in 2013. 2While opinions have 
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been published on the pros and cons of second stage modes of delivery, there is no 
consensus on which mode is better.3, 4
Previous studies that examine operative vaginal delivery have compared it to a baseline risk 
of complications from a spontaneous vaginal delivery and cesarean delivery. 56, 7 However, 
when a woman has a need for intervention in the second stage, spontaneous vaginal delivery 
is not an option she or the provider can choose. The appropriate clinical comparison is 
cesarean versus operative vaginal delivery. Furthermore, previous large studies have relied 
upon administrative data and thus were limited to evaluating final mode of delivery rather 
than attempted mode of delivery .5 Because successful operative delivery may have different 
outcomes than non-successful vaginal operative attempts, it is important to assess attempted 
delivery and not assign outcomes of failed operative attempts to the cesarean group.
There have been several small trials of operative vaginal delivery, but these compared 
forceps to vacuum or to spontaneous vaginal delivery. 8,9,10,11 In an arrest of labor or need 
for urgent delivery due to fetal tracing issues, spontaneous delivery is not a choice. In the 
studies that compared vacuum with forceps, there were a wide variety of stations as entry 
criteria, and because complications can vary with higher stations, these trials may not be 
directly applicable.
In the present day, a clinically relevant question is what to do when a patient has arrest of 
decent or has non-reassuring fetal status at fetal station of +2 or below. At these stations, 
with rare exception, most women are candidates for any of the three modes of delivery 
though the data are limited for clinicians to make informed decisions.
Our study sought to compare the maternal and neonatal complications with cesarean, vaginal 
vacuum, or vaginal forceps for women with a need for intervention in the second stage of 
labor and at a fetal station of +2 or below.
Materials and Methods
Between 2008 and 2011, we assembled a cohort of women and their neonates born at 25 
academically-affiliated hospitals in the Eunice Kennedy Shriver National Institute of Child 
Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network. This 
study, the Assessment of Perinatal EXcellence (APEX), designed to develop quality 
measures for intrapartum obstetrical care, was approved by the Institutional Review Board at 
each participating institution under a waiver of informed consent. Details regarding the 
APEX study have been previously described. 12 Briefly, patients eligible for data collection 
were those who delivered within the institution, were at least 23 weeks of gestation, and had 
a live fetus on admission. The medical records of all eligible women and their newborns 
were abstracted by trained and certified research personnel at the hospital and entered into a 
web-based data entry system. Data recorded included demographic characteristics, details of 
the medical and obstetrical history, information about intrapartum and postpartum events 
and patients’ race and ethnicity as reported in the chart. Maternal data were collected until 
discharge and neonatal data were collected up until discharge or until 120 days of age, 
whichever came first. This was a planned secondary analysis of the APEX data set.
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We created a subset of term (≥37 weeks) women with non-anomalous, vertex, singleton 
gestations, with no previa and no prior vaginal delivery, who had reached complete cervical 
dilation with a fetal station of +2 or below and were operatively delivered. The pelvic 
examination documenting station had to be within one hour of the decision to proceed with 
delivery. To be included women had to have one of the following indications for labor 
intervention: failure to descend, labor dystocia, maternal exhaustion, or non-reassuring fetal 
status. Because failure of operative vaginal delivery and need to proceed to cesarean is a 
known possibility, women were classified by whether they had an attempted vaginal vacuum 
or forceps delivery, not by whether that attempt was successful, i.e., not by final delivery 
mode. Women undergoing attempts at both vacuum and forceps vaginally were excluded 
from the main analysis, as that strategy need not be chosen by an operator, and its inclusion 
in could unfairly bias the results against an initial attempt at operative vaginal delivery. 
Because ACOG generally advises against two modes of operative attempt, these patients 
may be different in some unmeasurable way.13 Conversely, if an attempt at operative vaginal 
delivery was unsuccessful and proceeded to a cesarean delivery, it was included.
A subsequent supplemental analysis was performed to assess outcomes of women who 
failed the first attempt at operative vaginal delivery and went on to have a second attempt at 
a vaginal operative delivery with a different instrument
Maternal and neonatal outcomes were set a priori. A composite neonatal outcome was 
created that included the occurrence of any of the following: death, fracture other than 
clavicular, length of stay ≥3 days beyond mother’s hospital stay, Apgar < 4 at 5 minutes, 
subgaleal hemorrhage, ventilator support within 24 hours of birth on at least two days, 
hypoxic encephalopathy (HIE), brachial plexus injury, and facial nerve palsy. Secondary 
neonatal outcomes included skin laceration and brain bleed (intracranial or intraventricular 
hemorrhage (all grades)). Maternal outcomes included postpartum hemorrhage (defined as 
occurrence of any of the following: an estimated blood loss ≥1500 mL at delivery or the 
immediate postpartum period, a blood transfusion, or a hysterectomy for hemorrhage, 
placenta accreta, or atony), postpartum infection (defined as occurrence of any of the 
following: endometritis, wound cellulitis requiring antibiotics, wound reopened for fluid 
collection or infection, or wound dehiscence during the delivery hospitalization), and severe 
perineal laceration (defined as the occurrence of a third or fourth degree perineal laceration). 
Outcomes were examined by the three attempted modes of delivery. The final mode of 
delivery was also quantified.
Univariate comparisons of the patient population and outcomes were performed using chi-
square, Fisher’s exact and Kruskal-Wallis tests. Odds ratios were calculated adjusting for 
appropriate confounders using multivariable logistic regression. The c statistic was 
computed for each of the multivariable adjusted models. Model fit was assessed using the 
Hosmer-Lemeshow test. To determine whether associations varied by station or by 
birthweight, models with interaction terms (attempted mode of delivery × station and 
attempted mode of delivery × birthweight) were assessed. Because these tests for interaction 
were planned a priori, tests of interaction are generally underpowered, and our sample size 
was relatively small, P<.15 was used to define statistical significance for the interaction 
terms. P<.05 was used to define statistical significance for all other analyses. All tests were 
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two-tailed and no imputation for missing data was performed. All analyses were performed 
using SAS.
Results
Of the 115,502 women in the APEX data set, there were 2531 women who met criteria for 
the main analysis of this secondary analysis (Supplemental Figure). Demographic 
characteristics are shown in Table 1. Of the women included in this analysis, 16% were of 
Hispanic ethnicity and 11% were non-Hispanic black. The largest percent had an attempted 
vaginal vacuum delivery (54.6%) followed by attempted vaginal forceps (40.2%) and 
cesarean (5.2%). There were significant differences between women in age, race/ethnicity, 
smoking, BMI, intrapartum chorioamnionitis and birthweight, with larger babies more likely 
to be delivered by cesarean. Rotations were a minority of the forceps cases. Some vacuum 
deliveries were noted to have a rotation >45 degrees, despite the contraindication of applying 
torque with a vacuum. 14 It is unknown whether these were rotations that truly occurred with 
the vacuum on or inadvertently during the attempted delivery. Episiotomies were more 
frequent with vacuum than forceps deliveries (p<.001). Operator experience shows that the 
majority of operative deliveries were by an attending with more than 10 years of experience.
Table 2 shows the difference between delivery attempts by indication for operative delivery. 
Women undergoing an attempted operative vaginal delivery had more fetal indications than 
maternal indications. The majority of operative delivery attempts were low and not outlet as 
defined by ACOG.13 Lastly, vaginal vacuums had a higher frequency of failure and 
subsequent need for cesarean than vaginal forceps (p=.04).
Unadjusted frequencies of neonatal and maternal outcomes are shown in Table 3. There 
were no differences in the neonatal composite or its components between attempted modes 
of delivery with the exception of low Apgar score which was highest at cesarean delivery. 
Maternal outcomes showed significant differences with severe perineal lacerations being 
more frequent with vaginal forceps. Cesarean deliveries had the highest frequency of 
postpartum infections, as well as postpartum hemorrhages.
When potential confounding factors were taken into account, vaginal forceps and vacuum 
were associated with lower odds of postpartum infection (odds ratio 0.16, 95%CI 0.05-0.49; 
odds ratio 0.04, 95%CI 0.01-0.17, respectively), compared with cesarean delivery. The 
neonatal composite outcome and postpartum hemorrhage were not significantly different 
between the attempted operative vaginal and cesarean modes of delivery. Although 
postpartum hemorrhage was not significantly different between operative vaginal and 
cesarean modes of attempted delivery, an interaction at a p=.08 was observed between 
attempted mode of delivery and birthweight in an unadjusted model with interaction terms 
(due to small cell sizes, no other potentially confounding factors could be adjusted for). In 
those with birthweight<4000 grams, the frequency of postpartum hemorrhage was 1.0% in 
vaginal vacuum, 2.7% in vaginal forceps and 4.5% in cesarean. Correspondingly, vaginal 
vacuum (odds ratio 0.20, 95%CI 0.07-0.59), but not vaginal forceps (odds ratio 0.58, 95%CI 
0.22-1.54), were associated with a lower odds of postpartum hemorrhage compared with 
cesarean. In those with birthweight ≥4000 grams, the frequency of postpartum hemorrhage 
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was 8.8% in vaginal vacuum, 4.3% in vaginal forceps and 0.0% in cesarean; odds ratios not 
computed due to 0 cases in the cesarean group. No other significant interaction was 
observed. No third and fourth degree lacerations was observed in those whose first attempt 
was cesarean; therefore the multivariable model compared the two methods of operative 
vaginal deliveries (vaginal forceps odds ratio 2.20, 95%CI 1.80-2.70 compared with vaginal 
vacuum). Due to zero or small cells, the following outcomes were not assessed in 
multivariable analysis: neonatal skin laceration and neonatal intracranial or intraventricular 
hemorrhage.
The c-statistics for the multivariable adjusted models for the neonatal composite, maternal 
postpartum infection and maternal postpartum hemorrhage outcomes were 0.69 (95%CI 
0.64-0.73), 0.83 (95%CI 0.73-0.93), and 0.79 (95%CI 0.73-0.85), respectively. When 
comparing the c-statistics of multivariable models without and with attempted mode of 
delivery, a significant improvement was observed for the outcome of postpartum infection 
(0.74 vs. 0.83, p=.03). Based on the Hosmer-Lemeshow test, there was no evidence of a lack 
of fit in the multivariable adjusted models.
Of interest, there were 45 women who underwent both a vaginal vacuum and a vaginal 
forceps attempt. The characteristics and unadjusted outcomes show a 13.3% frequency of 
failure and need for cesarean delivery as well as a frequency of 28.9% for third or fourth 
degree tears and 6.8% for the neonatal composite outcome (Supplemental Table 1). 
Supplemental Table 2 shows the comparison between the frequency of outcomes in these 45 
women who underwent both a vaginal vacuum and a vaginal forceps attempt with the 133 
women who underwent one operative vaginal attempt followed by cesarean. Women 
undergoing a second operative vaginal attempt, compared with women who underwent a 
cesarean, had a higher frequency of a third or fourth degree tear. Small numbers of outcomes 
prevented an attempt to adjust for confounders with multivariate models.
Discussion
In many areas of the country, vacuum and forceps deliveries have decreased, likely due to 
legal concerns and the fact that fewer and fewer residents have extensive training in 
operative vaginal delivery. 15, 16 Our data suggest that for woman needing assistance in the 
second stage of labor at a fetal station of +2 or below, operative vaginal delivery is 
associated with the least infectious morbidity. Compared with forceps delivery, vacuum 
delivery is associated with fewer third and fourth degree tears, although it also is more likely 
to result in a failed attempt and cesarean delivery.
Our study is an important advancement over previous studies in that it examines attempted 
mode of delivery rather than ultimate mode of delivery. When assessing ultimate mode of 
delivery, only the unsuccessful and more complicated cases will proceed to cesarean and the 
easier cases will be successful operative vaginal deliveries. By assessing attempted mode of 
delivery, we can evaluate outcomes regardless of whether the attempt was successful, a 
design that is analogous to an intent to treat analysis in a clinical trial.
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While cesarean was not significantly associated with the adverse neonatal composite, 
cesarean was associated with a higher odds of maternal postpartum infection. After adjusting 
for confounders, attempted mode of delivery was not associated with postpartum 
hemorrhage; however, our data suggest that the association may vary by the size of the baby 
with vaginal vacuum deliveries associated with a lower frequency of postpartum hemorrhage 
in babies < 4000 grams, but with a higher frequency of postpartum hemorrhage in babies ≥ 
4000 grams.
Our study is not without limitations. Patients in this study were from hospitals that are 
affiliated with academic institutions, and may not be generalizable to non-academic 
institutions. Even when adjusting for confounders, the possibility of unmeasured baseline 
differences between the populations remains. As with any cohort, there may be a selection 
bias when deciding which mode of delivery is attempted first, such as concern regarding the 
fetus, that is unmeasurable and not accounted for in the analysis. Additionally, some infant 
outcomes of interest were too rare to compare between groups and some are specific to a 
mode of delivery, for example severe vaginal tears do not occur with cesarean deliveries. 
While some types of clinical problems are amenable to study by randomized trial, it is 
unlikely that a trial comparing vaginal vacuum, vaginal forceps and cesarean for second 
stage arrest at a fetal station of +2 or below will be performed. Thus, an evaluation of an 
obstetric cohort from multiple centers with high quality clinical data takes on new 
importance.
Our study suggests that operative vaginal delivery is a reasonable first choice in the second 
stage at fetal station of +2 or below. While there may be specific situations when cesarean is 
an appropriate clinical choice, the risks and benefits of any attempted mode of delivery must 
be considered, discussed with the family and documented.
Conclusions
In patients needing second stage delivery assistance who have a fetal station of +2 or below, 
attempted operative vaginal delivery was associated with the least infectious morbidity. 
Vacuum delivery was associated with fewer third and fourth degree tears compared with 
forceps but had a higher rate of failure resulting in cesarean delivery.
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Table 1
Demographic characteristics by attempted mode of delivery
First Operative Attempt
Characteristics, n (%)
unless otherwise indicated
Vaginal trial of
vacuum
n=1382
Vaginal trial of
forceps
n=1018
Cesarean
n=131 P-value*
Age , years <.001
  <25 502 (36.3) 331 (32.5) 27 (20.6)
  25-29.9 385 (27.9) 252 (24.8) 37 (28.2)
  30-34.9 346 (25.0) 299 (29.4) 43 (32.8)
  ≥35 149 (10.8) 136 (13.4) 24 (18.3)
Race/ethnicity <.001
  Non-Hispanic white 776 (56.2) 602 (59.1) 74 (56.5)
  Non-Hispanic black 198 (14.3) 80 (7.9) 8 (6.1)
  Hispanic 201 (14.5) 171 (16.8) 25 (19.1)
  Other 207 (15.0) 165 (16.2) 24 (18.3)
Diabetes (pre-gestational
or gestational) 68 (4.9) 46 (4.5) 10 (7.6) .30
Smoking 116 (8.4) 57 (5.6) 6 (4.6) .02
PROM 34 (2.5) 28 (2.8) 4 (3.1) .87
Hypertension (chronic or
preeclampsia) 139 (10.1) 109 (10.7) 14 (10.7) .86
BMI, kg/m2 .02
  <25 240 (17.5) 169 (16.8) 9 (7.0)
  25-29.9 583 (42.6) 465 (46.3) 56 (43.8)
  30-34.9 364 (26.6) 252 (25.1) 42 (32.8)
  35-39.9 126 (9.2) 70 (7.0) 14 (10.9)
  ≥40 56 (4.1) 48 (4.8) 7 (5.5)
Cocaine/meth 5 (0.4) 5 (0.5) 1 (0.8) .48
Prior cesarean 42 (3.0) 32 (3.1) 5 (3.8) .89
Intrapartum
chorioamnionitis 162 (11.7) 188 (18.5) 32 (24.4) <.001
Gestational age, weeks .10
Am J Obstet Gynecol. Author manuscript; available in PMC 2017 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Bailit et al. Page 12
First Operative Attempt
Characteristics, n (%)
unless otherwise indicated
Vaginal trial of
vacuum
n=1382
Vaginal trial of
forceps
n=1018
Cesarean
n=131 P-value*
  370-376 94 (6.8) 67 (6.6) 6 (4.6)
  380-386 222 (16.1) 143 (14.1) 17 (13.0)
  390-396 417 (30.2) 269 (26.4) 42 (32.1)
  400+ 649 (47.0) 539 (53.0) 66 (50.4)
Length of second stage,
hours† 2.2 ± 1.6 2.5 ± 1.6 3.8 ± 1.7 <.001
Birthweight ≥4000 grams 83 (6.0) 71 (7.0) 21 (16.0) <.001
Birthweight, grams, mean ±
sd 3338 ± 422 3370 ± 426 3537 ± 442 <.001
Rotation >450 when
vacuum or forceps applied† 53 (4.1) 61 (6.5) .01
‡
Episiotomy 514 (37.2) 288 (28.3) 2 (1.5) <.001
Cystotomy 1 (0.1) 1 (0.1) 0 (0.0) 1.00
Bowel injury 0 (0.0) 1 (0.1) 0 (0.0) §
Ureteral injury 0 (0.0) 0 (0.0) 0 (0.0) §
Accreta 1 (0.1) 0 (0.0) 0 (0.0) §
Attending years since
graduation <.001
  < 10 320 (23.5) 174 (17.2) 46 (35.9)
  10.0-14.9 273 (20.0) 219 (21.6) 26 (20.3)
  15.0-19.9 239 (17.5) 179 (17.7) 13 (10.2)
  20.0-9.9 224 (16.4) 142 (14.0) 16 (12.5)
  ≥ 25.0 307 (22.5) 298 (29.5) 27 (21.1)
PROM, premature rupture of membranes; BMI, body mass index
*based on chi-square, Fisher’s exact or Kruskal-Wallis
†length of second stage missing in 2.8%; rotation >450 missing in 6.7% of vaginal operative attempts
‡p-value comparing vaginal trial of vacuum and vaginal trial of forceps as this was not applicable in cesarean as first operative attempt
§p-value not computed due to zero observations in two or more groups
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Table 2
Description of operative attempts
First Operative Attempt
Information about the first
operative attempt, n (%)
Vaginal trial of
vacuum
n=1382
Vaginal trial of
forceps
n=1018
Cesarean
n=131 P-value*
Fetal indication for first
operative attempt (non-
reassuring fetal status)
703 (50.9) 441 (43.3) 23 (17.6) <.001
Station at first operative
attempt was outlet† 607 (43.9) 274 (26.9) 12 (9.2) <.001
Final delivery mode was
cesarean
88 (6.4) 45 (4.4) 131 (100.0) <.001‡
*based on chi-square
†defined as a fetal station of +3 when using the 3rds scale or +5 when using the 5ths scale
‡p=.04 comparing vaginal trial of vacuum with vaginal trial of forceps
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Table 3
Outcomes by attempted mode of delivery (unadjusted)
First Operative Attempt
Outcomes, n (%)
Vaginal trial of
vacuum
n=1382
Vaginal trial of
forceps
n=1018
Cesarean
n=131 P-value*
Neonatal outcomes
Primary neonatal composite
outcome 58 (4.2) 61 (6.1) 9 (6.9) .09
  Components of the
  composite
  Stillbirth after admission 0 (0.0) 0 (0.0) 0 (0.0) †
  Neonatal death 0 (0.0) 1 (0.1) 0 (0.0) †
  Fracture other than
  clavicular 2 (0.1) 0 (0.0) 0 (0.0) †
   Skull 1 (0.1) 0 (0.0) 0 (0.0) †
   Depressed skull 0 (0.0) 0 (0.0) 0 (0.0) †
   Other 1 (0.1) 0 (0.0) 0 (0.0) †
  Stay > mom by 3+ days 40 (2.9) 47 (4.6) 6 (4.6) .07
  Low Apgar 5 (0.4) 5 (0.5) 3 (2.3) .01
  Subgaleal 6 (0.4) 1 (0.1) 0 (0.0) .33
  Vent support 4 (0.3) 3 (0.3) 1 (0.8) .44
  HIE 11 (0.8) 11 (1.1) 3 (2.3) .24
  Brachial plexus injury 4 (0.3) 3 (0.3) 0 (0.0) 1.00
  Facial nerve palsy 0 (0.0) 5 (0.5) 0 (0.0) †
Secondary neonatal
outcomes
Skin laceration 30 (2.2) 29 (2.9) 1 (0.8) .26
Bleed 14 (1.0) 5 (0.5) 0 (0.0) .20
Maternal outcomes
Severe perineal laceration 263 (19.1) 344 (33.8) 0 (0.0) <.001
Postpartum infection 3 (0.2) 9 (0.9) 7 (5.3) <.001
Postpartum hemorrhage‡ 19 (1.4) 28 (2.8) 5 (3.8) .03
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*based on chi-square or Fisher’s exact
†p-value not computed due to zero observations in two or more groups
‡
Postpartum hemorrhage missing in 2.8%
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Table 4
Outcomes by attempted mode of delivery accounting for confounders
Outcomes, odds ratio (95%CI)
Vaginal trial of vacuum
n=1382
Vaginal trial of forceps
n=1018
Cesarean
n=131
Neonatal composite* 0.64 (0.29-1.39) 0.90 (0.42-1.93) referent
Maternal postpartum infection† 0.04 (0.01-0.17) 0.16 (0.05-0.49) referent
Maternal postpartum hemorrhage* 0.56 (0.19-1.68) 0.79 (0.28-2.25) referent
*
adjusted for operative delivery indication, station, length of second stage, maternal age, diabetes, smoking, premature rupture of membranes, 
hypertension, prior cesarean, body mass index, chorioamnionitis, birthweight
†
adjusted for operative delivery indication, station, length of second stage, maternal age, smoking, premature rupture of membranes, intrapartum 
chorioamnionitis, birthweight
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